Bevacizumab Versus Combined Bevacizumab and Triamcinolone for Refractory Diabetic Macular Edema; a Randomized Clinical Trial

This study is ongoing, but not recruiting participants.

Study NCT00370422 Information provided by Shaheed Beheshti Medical University

First Received: August 30, 2006 Last Updated: March 12, 2007 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	September 2006
Estimated Primary Completion Date:	No date given

No publications provided by Shaheed Beheshti Medical University

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Ahmadieh H, Ramezani A, Shoeibi N, Bijanzadeh B, Tabatabaei A, Azarmina M, Soheilian M, Keshavarzi G, Mohebbi MR. Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular edema; a placebo-controlled, randomized clinical trial. Graefes Arch Clin Exp Ophthalmol. 2008 Apr;246(4):483-9. Epub 2007 Oct 5.